These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16304865)

  • 1. Childhood visceral leishmaniasis in Muzaffarabad, Azad Jammu and Kashmir: frequency and response to treatment in 61 cases.
    Altaf C; Ahmed P; Ashraf T; Anwar M; Ahmed I
    J Pak Med Assoc; 2005 Nov; 55(11):475-8. PubMed ID: 16304865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features of childhood visceral leishmaniasis in Azad Jammu & Kashmir Pakistan.
    Altaf C; Ahmed P; Ashraf T; Anwar M; Ahmed I
    J Ayub Med Coll Abbottabad; 2005; 17(4):48-50. PubMed ID: 16599035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
    Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
    Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
    Piarroux R; Garnier JM; Gambarelli F; Dumon H; Kaplanski S; Unal D
    Arch Pediatr; 1996 Apr; 3(4):352-6. PubMed ID: 8762958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
    Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
    Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
    Gramiccia M; Gradoni L; Orsini S
    Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis in clinical practice.
    Davidson RN
    J Infect; 1999 Sep; 39(2):112-6. PubMed ID: 10609527
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiological and clinical features of visceral leishmaniasis in children in Alicante Province, Spain.
    Ramos JM; Clavijo A; Moral L; Gavilan C; Salvador T; González de Dios J
    Paediatr Int Child Health; 2018 Aug; 38(3):203-208. PubMed ID: 29790825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
    Silveira LJ; Rocha TJ; Ribeiro SA; Pedrosa CM
    Rev Inst Med Trop Sao Paulo; 2015; 57(1):33-8. PubMed ID: 25651324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of visceral leishmaniasis in Colombia resistant to meglumine antimonial treatment.
    Vélez ID; Colmenares LM; Muñoz CA
    Rev Inst Med Trop Sao Paulo; 2009; 51(4):231-6. PubMed ID: 19739006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus.
    Ferreira E; Lucena S; Fonseca G; Barbosa TC; Aquino RB; Lambert JS; Nogueira SA
    Pediatr Infect Dis J; 2001 Feb; 20(2):224-6. PubMed ID: 11224850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis in District Dir, NWFP.
    Rahim F; Rehman F; Ahmad S; Zada B
    J Pak Med Assoc; 1998 Jun; 48(6):161-2. PubMed ID: 9813985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
    Rodilla F; Magraner J; Aznar J; Orovitg F; Alcácer F; Colomina J; Ferriols F
    Ann Pharmacother; 1994 Nov; 28(11):1305. PubMed ID: 7849352
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R; Rambaldi A; Tripodi MF; Andreana A
    Infection; 1995; 23(3):182-3. PubMed ID: 7499009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
    J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.